Latest News and Press Releases
Want to stay updated on the latest news?
-
Surrozen Reports First Quarter 2025 Financial Results and Business Update
-
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics First-in-class peptidomimetic with distinct MoA activating...